for healthier lives through innovation in the development of safe and residual-free therapies for animal health
administered at the beginning of the dry-off period (Imilac™) and during lactation (Milac™). These products will revolutionize the way in which veterinarians treat a wide range of diseases, including clinical and subclinical mastitis. They will replace antibiotics on dairy farms, and provide additional and significant economic value to farmers by increasing milk yield and profitability while improving the cows’ well-being. Additional products using Mileutis’ residue-free immunomodulatory platform with casein-derived peptides are under development.